Friday 6 November 2026 Export NTRA’s income statement to Excel — free account

Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue: +34.1%
EPS: +34.4%
Free cash flow: −85.8%
Total debt: −0.06%

Quarter to September 2026, against a year earlier

316.48 47.28 −13.00%

Follow NTRA

Alert me

Market cap: $52.4B
P/E: 0.0×
Fwd P/E: −289×
Dividend yield: —
F-score: 6/9
Altman Z: 26.84
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Natera, Inc. (NTRA) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Natera, Inc. (NTRA) trades at a price to free cash flow of 1,004×. Over the past ten years it has ranged from 0.0× (December 2024) to 1,197× (October 2026); the current reading is higher than 99% of that period. That is above the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NTRA/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Natera, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NTRA/metrics/price-to-free-cash-flow">Natera, Inc. (NTRA) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	287×	0.67%
FY2024	285×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	Price to free cash flow	Change
Sep 2026	1,135×	145.68%
Jun 2026	462×	70.59%
Mar 2026	271×	(5.67%)
Dec 2025	287×	37.87%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 1,197×

Ten-year median 0.0×

Current reading's percentile 99

Company	Price to free cash flow
DGX Quest Diagnostics Incorporated compare	20.3×
IQV IQVIA Holdings Inc. compare	21.0×
LH Labcorp Holdings Inc. compare	25.4×
ILMN Illumina, Inc. compare	30.4×
A Agilent Technologies, Inc. compare	38.2×
MTD Mettler-Toledo International, Inc. compare	39.1×
IDXX IDEXX Laboratories, Inc. compare	40.6×
WAT Waters Corporation compare	173×
NTRA Natera, Inc.	1,004×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Natera, Inc. (NTRA) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NTRA

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NTRA

Stockrow Weekly